Oocyte diameter as a predictor of fertilization and embryo quality in assisted reproduction cycles

Size: px
Start display at page:

Download "Oocyte diameter as a predictor of fertilization and embryo quality in assisted reproduction cycles"

Transcription

1 Oocyte diameter as a predictor of fertilization and embryo quality in assisted reproduction cycles Gustavo Salata Rom~ao, Ph.D., Maria Cristina Picinato Medeiros Araujo, B.S., Anderson Sanches de Melo, M.D., Paula Andrea de Albuquerque Salles Navarro, Ph.D., Rui Alberto Ferriani, Ph.D., and Rosana Maria dos Reis, Ph.D. Department of Obstetrics and Gynecology, Faculty of Medicine of Ribeir~ao Preto, University of S~ao Paulo, Ribeir~ao Preto, S~ao Paulo, Brazil Objective: To assess the impact of the mean oocyte diameter (MOD) on occurrence of fertilization and embryo quality in assisted reproduction cycles. Design: Prospective observational study. Setting: Sector of Human Reproduction of the University Hospital, Faculty of Medicine of Ribeir~ao Preto, University of S~ao Paulo (HCFMRP-USP). Patient(s): Thirty-five women undergoing intracytoplasmic sperm injection (ICSI) at the University Hospital of Ribeir~ao Preto from May to October Intervention(s): MOD assessment. Main Outcome Measure(s): Occurrence of fertilization and qualitative embryo classification on 2nd and 3rd day after ICSI. Result(s): We divided 160 metaphase II oocytes according to MOD into groups A (MOD below the 25th percentile), B (MOD between 25th and 75th percentile), and C (MOD above the 75th percentile). There was no statistically significant association between MOD and the occurrence of fertilization or the qualitative embryo classification on days 2 and 3. There was no statistically significant difference between groups regarding number of cells or the qualitative embryo classification on days 2 and 3. Conclusion(s): The MOD of mature oocytes does not seem to be related to the occurrence of fertilization or to the developmental quality of human embryos on days 2 and 3 after ICSI. (Fertil Steril Ò 2010;93: Ó2010 by American Society for Reproductive Medicine.) Key Words: Mean oocyte diameter, ICSI, fertilization, embryo quality, assisted reproduction Received June 6, 2008; revised December 12, 2008; accepted December 19, 2008; published online May 6, G.S.R. has nothing to disclose. M.C.P.M.A. has nothing to disclose. A.S. de M. has nothing to disclose. P.A. de A.S.N. has nothing to disclose. R.A.F. has nothing to disclose. R.M. dos R. has nothing to disclose. Supported by the Laboratory of Human Reproduction, Hospital of Clinics of the Faculty of Medicine of Ribeir~ao Preto, University of S~ao Paulo. Reprint requests: Gustavo Salata Rom~ao, Ph.D., Department of Medicine, Federal University of S~ao Carlos, Rodovia Washington Luıs, km 235, SP-310, S~ao Carlos, S~ao Paulo, Brazil (FAX: ; gsalata@uol.com.br). During growth, mammalian oocytes stagnate in prophase I of the first meiotic division in the diplotene I stage, also known as the germinal vesical stage (GV). Fully grown oocytes can resume the division process and reach metaphase II both in vivo after the luteinizing hormone (LH) peak and in vitro after their release from the follicular units. In contrast, oocytes that have not completed their full growth cannot resume or complete meiosis (1). Competence for meiotic resumption is believed to be acquired during the phase of oocyte growth, when the processes of synthesis and storage of proteins and of ribosomal and heterogeneous RNA take place. These events lead not only to nuclear maturation but also to the cytoplasmic modifications necessary for the development of the future embryo. These modifications include [1] protein and RNA storage, [2] development of mechanisms that regulate intracellular calcium transport, [3] redistribution of cytoplasmic organelles, and [4] modulation of kinase protein activity (2). Some of the factors that determine the acquisition of meiotic competence are still controversial. Schultz and Wassarman (3) suggested that the acquisition of competence and the maturation of rat oocytes occur in two distinct stages. Initially, the oocytes acquire the ability to resume meiosis, and later they acquire the competence for meiotic maturation. These investigators observed that the growth of rat oocytes is accompanied by significant changes in the types of proteins synthesized in each phase. Additionally, oocyte metabolism seems to be modified during growth, in agreement with findings of an increase in the total activity of the enzymes lactate dehydrogenase and glucose-6-phosphate dehydrogenase. It has been demonstrated in many species that a critical oocyte size is necessary for the resumption of meiosis and maturation. According to Otoi et al. (4), canine oocytes acquire meiotic competence when they reach a diameter of more than 120 mm, although the ability of sperm penetration does not depend on oocyte diameter. In a study of oocytes from goats aged 1 to 2 months (prepubertal phase) with in vitro maturation (IVM) and fertilization (IVF), Anguita et al. (5) demonstrated that oocyte diameter was positively correlated with the percentage of /10/$36.00 Fertility and Sterility â Vol. 93, No. 2, January 15, doi: /j.fertnstert Copyright ª2010 American Society for Reproductive Medicine, Published by Elsevier Inc.

2 oocytes that reached metaphase II and with the percentage of fertilized oocytes that developed beyond the blastocyst stage. Oocyte diameter was also positively correlated with the intracellular amount of the p34 protein and with the degree of activity of maturation promoting factor. The highest percentage of blastocysts (12%) was obtained from oocytes with a diameter of more than 135 mm on the day of retrieval, which originated from follicles measuring 2 to 3 mm in diameter. The investigators concluded that the impaired development of embryos from oocytes of prepubertal goats may be related to oocyte diameter more than to the physiologic condition of the animals. Goat oocytes acquire meiotic competence when their diameter is more than 136 mm, both in adult (6) and prepubertal (7) females. Although several studies have evaluated the relation between oocyte diameter and the capacity for maturation and embryo development in different animal species, little information on this topic is available about human oocytes. Griffin et al. (8) carried out a comparative analysis of follicle and oocyte diameter in four different species rats, mice, pigs, and humans. The investigators described in detail for the first time the differences between experimental models of folliculogenesis and identified variations in the histologic pattern of the ovarian follicles among the four species studied. Their conclusion was that the relation between oocyte diameter and degree of maturation is species-specific and should not be generalized or extrapolated to other animal models. In a study using oocytes from women who were undergoing surgical procedures for nonovarian disorders, Durinzi et al. (9) demonstrated that the ability of human oocytes from nonstimulated cycles to resume meiosis and complete IVM was correlated with oocyte diameter at the time of retrieval. Thus, the maturation potential of immature oocytes must be related to the level of growth reached by the oocytes inside the follicles before the detachment provoked by ovulation. The specificity of and the mechanisms involved in the relationship of metabolism, protein synthesis, and cytoplasm maturation with meiotic competence and embryo development in human oocytes are still under investigation. In a recent study, Cavilla et al. (10) used IVM to evaluate oocytes obtained from women with polycystic ovary syndrome (POS) and demonstrated that larger oocytes had a better probability of maturation. In the same study, 20 mature oocytes retrieved from women undergoing intracytoplasmic sperm injection (ICSI) were evaluated, and no significant relation was observed between oocyte diameter and probability of fertilization or embryo cleavage, although a small number of oocytes was evaluated. The use of noninvasive measures such as mean oocyte diameter (MOD) for oocyte evaluation to predict the results of ICSI is of great clinical importance, permitting a better selection of the oocytes for insemination and better control of the quantity and quality of the embryos obtained, reducing to a minimum the ethical problems related to embryo freezing. Our main objective was to assess the impact of MOD on fertilization and embryo quality in assisted reproduction cycles. We also investigated the relations among MOD, maternal age, and basal follicle-stimulating hormone (FSH) levels. MATERIALS AND METHODS The study was conducted in the Sector of Human Reproduction of the University Hospital, Faculty of Medicine of Ribeir~ao Preto, University of S~ao Paulo (HCFMRP-USP), and the investigation project was submitted and approved by our institutional review board. Thirty-five women who underwent ovarian stimulation and oocyte retrieval for assisted fertilization at HCFMRP-USP were selected between May and October 2007 after giving written, informed consent to participate in the study. The age of the selected patients ranged from 24 to 42 years (mean þ standard deviation [SD]: ), and their basal FSH levels ranged from 2.4 to 17.8 IU/L (mean þ SD: IU/L). Patients with suspected endometriosis or confirmed disease by videolaparoscopy and patients whose sexual partners presented with severely compromised seminal parameters (sperm morphology of less than 8% in the spermiogram and/or sperm concentration of less than 2 million in the seminal fluid recovered) were excluded from the study. The investigation of conjugal infertility revealed the presence of male factor infertility in 25 couples (77.1%) (17 cases of asthenoteratozoospermia, four of asthenozoospermia, three of mild oligozoospermia, and one of teratozoospermia), of tubal factor infertility in nine couples (25.7%), ovulatory factor in eight (22.9%), and uterine factor in one (2.9%), with the presence of more than one infertility factor observed in nine couples. Four of the patients in the study (11.4%) were trying assisted reproduction for the first time, 16 (45.7%) for the second time, eight (22.9%) for the third time, five (14.3%) for the fourth time, and two (5.7%) for the fifth time. Protocol of Assisted Fertilization The menstrual period was programmed with the use of combined oral contraceptives started during the preceding cycle and discontinued 5 days before the date scheduled for the beginning of ovarian stimulation. For pituitary suppression, leuprolide acetate (Lupron, Abbott Pharmaceuticals, Abbott Park, IL; or Reliser, Serono, S~ao Paulo, Brazil; 10 IU/day by the subcutaneous route) was administered to nine patients (25.7%) and nafarelin (Synarel; Pharmacia, S~ao Paulo, Brazil; 400 mg/day by the nasal route) was administered to 26 patients (74.3%) starting 10 days before the programmed menstruation and maintained until the day of human chorionic gonadotropin (hcg) administration. Once ovarian suppression was confirmed by transvaginal ultrasound from the first to the third day of the menstrual cycle, controlled ovarian stimulation was started with recombinant FSH (Puregon, Organon, S~ao Paulo, Brazil; or Gonal-F, Serono) at the dose of 622 Rom~ao et al. Oocyte diameter and embryo quality Vol. 93, No. 2, January 15, 2010

3 200 to 450 IU/day on the first 5 days, adjusted according to the ovarian response starting on the six day of stimulation. Urinary human chorionic gonadotropin (Profasi; Serono), 10,000 IU, was administered intramuscularly, or recombinant hcg (Ovidrel, Serono), 250 mg, was administered subcutaneously when two or more follicles R18 mm in mean diameter were present. Oocytes were retrieved by puncture of the vaginal sac guided by transvaginal ultrasound 34 to 36 hours after hcg administration. The follicular content was aspirated under negative pressure of 100 mm Hg into Falcon tubes and kept at 37 C. The cumulus oocyte complexes (COC) were separated from the follicular fluid under a stereomicroscope, washed in human tubal fluid (HTF) culture medium modified with HEPES (Irvine Scientific, Santa Ana, CA) supplemented with 10% synthetic serum substitute (SSS; Irvine Scientific), and transferred to culture plates previously incubated at 37 C in the presence of 5% CO 2 in air, containing HTF culture medium (Irvine Scientific) supplemented with 10% SSS. After 2 to 5 hours of incubation in this culture medium, cumulus cells were removed by exposing the COC to hyaluronidase (H-4272; Sigma-Aldrich, St. Louis, MO) at the concentration of 80 IU/mL, in HTF-HEPES supplemented with 10% SSS for 30 seconds, followed by mechanical removal with glass pipettes. Semen samples were obtained immediately after oocyte retrieval and were manipulated and analyzed for the ICSI procedure according to recommended procedures for male infertility. Before ICSI, the denuded oocytes were placed in 5-mL microdroplets of HTF-HEPES supplemented with 10% SSS on Falcon plates and were observed under an inverted microscope with Hoffman optic contrast at 400 magnification. The MOD was calculated immediately after oocyte denudation. We performed ICSI as described previously elsewhere, 36 to 41 hours after hcg administration. After ICSI, the oocytes were incubated separately in 25-mL microdroplets of HTF þ 10% SSS at 37 C in the presence of 5% CO 2 in air. Fertilization was determined 18 to 20 hours after ICSI on the basis of the presence of two pronuclei and of two polar corpuscles. Oocytes presenting one, three, or more pronuclei were classified as abnormal; they were considered inviable and later discarded. Cleavage was verified about 24 hours after fertilization by the observation of the first cell division. Embryo quality was assessed on the basis of variables such as percentage of cytoplasmic fragmentation, symmetry, and number of blastomeres (11). Embryos with four cells, symmetrical blastomeres, and no fragmentation on the second day after retrieval (D2) and embryos with eight or more cells and 20% fragmentation or less on the third day after retrieval (D3) were considered to be of good quality. Embryo transfer was performed on the third day after retrieval, and the luteal phase was supplemented with micronized progesterone administered orally or vaginally up to the 12th week of pregnancy or until the occurrence of menstruation. Pregnancy was confirmed by serum determination of b-hcg on the 14th day after transfer. Mean Oocyte Diameter (MOD) The MOD was determined on the day of retrieval immediately after the removal of cumulus cells using OCTAX Eye- Ware software (Universal Imaging Corp., Boston, MA). Two perpendicular measurements were made for each oocyte, excluding the zona pellucida. The maximum value obtained in each parallel measurement was used as the reference value. The MOD was obtained by the arithmetic mean of the two perpendicular measurements. Statistical Analysis The correlations among MOD values, maternal age, basal FSH levels, and number of cells on D2 and D3 were determined by the Pearson coefficient. The correlations among MOD values, occurrence of fertilization, number of cells, and qualitative embryo classification on D2 and D3 were determined by analysis of the receiver operating characteristic (ROC) curve. For further analysis of these parameters, oocytes were divided according to MOD into groups: group A, MOD below the 25th percentile; group B, MOD between 25th and 75th percentile; and group C, MOD above the 75th percentile. Comparisons among groups were performed by using the chi-square test. P<.05 was considered statistically significant. RESULTS A total of 160 metaphase II oocytes was obtained in 35 cycles from 35 women included in the study. The number of oocytes retrieved per patient ranged from one to 10 (mean SD: ). The oocytes retrieved had a MOD of to mm, with a median of mm and a mean SD of mm. The MOD was not statistically significantly correlated with maternal age (r ¼ ; P¼.3082) or with basal FSH levels (r ¼ ; P¼.0611). Also, no correlation was observed between maternal age and basal FSH levels (r ¼ ; P¼.0818) in the patients studied. There was no statistically significant association between MOD and the occurrence of fertilization (P¼.5044), or qualitative embryo classification on D2 and D3 (P¼.2777 and , respectively). There was no statistically significant association between MOD and the number of cells on D2 (r ¼ ; P¼.5975) or D3 (r ¼ ; P¼.1899). The comparisons of groups A (MOD < mm), B (MOD between mm and mm), and C (MOD > mm) are shown in Table 1. The fertilization rates for groups A, B, and C were 82.5%, 68.75%, and 75%, respectively, with no statistically significant difference (P¼.2662). Fertility and Sterility â 623

4 TABLE 1 Comparison of the embryonic parameters of groups A, B, and C by the chi-square test. Day Parameter Group A Group B Group C P value: A versus B versus C 1 Number of oocytes Mean oocyte diameter (mm) < a a b > b Fertilized 33 (82.5%) 55 (68.75%) 30 (75%) R4 cells 12 (38.7%) 31 (56.4%) 15 (50%).2906 Good quality 16 (51.6%) 22 (42.3%) 10 (34.5%) R8 cells 12 (57.1%) 16 (53.3%) 24 (77.4%).117 Good quality 10 (47.6%) 9 (31%) 11 (52.4%).2689 a 25th percentile. b 75th percentile. Rom~ao. Oocyte diameter and embryo quality. Fertil Steril There was no statistically significant difference between the groups regarding the number of cells (P¼.2906) or the qualitative embryo classification on D2 (P¼.4051) or D3 (P¼.117 and.2689, respectively). Among the 35 cycles analyzed, 32 embryo transfers were performed (91.4%), with a mean number of embryos per embryo transfer of two. DISCUSSION Studies on different species have elucidated the relation between oocyte diameter and competence for maturation and embryo development. Eppig and Schroeder (12) demonstrated in rats that the successive stages of meiotic maturation and embryogenesis were related to oocyte age and size. According to these findings, although the oocytes with a diameter of more than 60 mm from mice of younger than 13 days old were able to progress to germinal vesicle breakdown in culture, larger oocytes obtained from mice older than 15 days were more likely to complete metaphase II (MII) in culture. Hirao et al. (13) confirmed that the minimum oocyte diameter needed for meiotic maturation in mice is 60 mm, even for in vitro growth. Similar evidence was obtained with rats (14) and pigs (15), for which the minimum diameters needed for germinal vesicle breakdown were 55 and 90 mm, respectively. The continued transcription observed in bovine oocytes indicates that the maternal RNA complement, necessary for early embryo development, may still be incomplete, suggesting a possible mechanism for the association between oocyte growth and acquisition of the capacity for maturation (16). The capacity for cleavage after maturation and in vitro insemination is also related to the increase in oocyte age and diameter. In mouse oocytes, the competence for maturation was found to be acquired as the diameter increased from 65 to 75 mm, and the modifications occurring in the final stages of oocyte growth were critical to reach full maturation (17). However, the relation between oocyte diameter and degree of maturation may differ significantly between animal species. In the oocytes of Rhesus monkeys the oocyte diameter remains relatively stable as competence for germinal vesicle breakdown (GVBD) is acquired (18). Although several studies have evaluated the relation between oocyte diameter and the ability for maturation and embryo development in different animal species, little information is available about this topic for human oocytes despite the accessibility of this data during assisted fertilization procedures and IVM. In a study on humans, 49 oocytes were obtained from six women aged 25 to 39 years (a mean of 4 to 11 oocytes per patient) who were undergoing surgery for ovarian disease (9). The oocytes were evaluated for diameter (mm) and degree of maturation according to parameters established in the literature (GV, presence of the germinal vesicle; MI, rupture of the germinal vesicle; or MII, extrusion of the first polar corpuscle). Only one third of the oocytes with a diameter of less than 105 mm were able to resume meiosis or to mature, as opposed to more than two thirds of the oocytes with a diameter of more than 105 mm. Evaluation of oocyte diameter in the final stage of maturation revealed that, among oocytes with a diameter between 116 and 125 mm, 60% were in MII as opposed to only 44% of those with a diameter of less than 115 mm. It was also revealed that, among oocytes in the GV stage, those with a diameter between 116 and 125 mm progressed more rapidly to GV rupture and extrusion of the first polar corpuscle compared with oocytes with a diameter of less than 115 mm. These results support the idea that human oocytes, as is the case for other species, present a size-dependent latency to progress in the division process until complete maturation. Cavilla et al. (19), using computerized micrographic images of human oocytes in culture for IVM, confirmed the findings of Durinzi et al. (9), which had suggested the potential of noninvasive oocyte measurements as predictors of subsequent ability to develop. Cavilla et al. (10) also evaluated via IVM 86 oocytes obtained from women with polycystic 624 Rom~ao et al. Oocyte diameter and embryo quality Vol. 93, No. 2, January 15, 2010

5 ovary syndrome. The diameter of the 28 oocytes that survived and progressed in IVM ranged from 103 and 121 mm, with a median of 108 mm. Of these, 10 progressed to fertilization (presenting two pronuclei) after ICSI, with a diameter ranging from 105 to 121 mm (median: mm). The investigators concluded that oocytes that were larger when collected for IVM had a greater probability to mature. In the same study, 20 mature oocytes retrieved for ICSI from 17 women aged 22 to 35 years (mean: 28.1 years) were evaluated. The MOD measured after the removal of cumulus cells and before ICSI ranged from 112 to 119 mm, with a mean of 116 mm. In contrast to the results for IVM, no statistically significant relation was observed between MOD and probability of fertilization or embryo cleavage, probably because of the small number of oocytes observed. The mean oocyte diameter observed in our study ( mm) was similar to the value obtained by Cavilla et al. (10) for oocytes inseminated after IVM (112.5 mm) and was close to the value obtained for IVM oocytes submitted to ICSI (116 mm). As also reported in previous studies (10), our study found no statistically significant association between oocyte diameter and the occurrence of fertilization, number of cells, or embryo quality at D2 and D3. These results may have been due to the fact that among the 160 evaluated oocytes, only one had a MOD value below the cutoff level (105 mm) for which statistically significant differences were observed regarding the ability to resume meiosis or to obtain maturation (9). In comparison with the study by Cavilla et al. (10) in which the MOD of oocytes matured in vitro for ICSI ranged from 109 to 118 mm, we observed a greater oscillation of this variable ( to mm), which could be attributed in part to the different number of oocytes evaluated by Cavilla et al. (10) (n ¼ 20) and by us (n ¼ 160). In addition, Cavilla et al. (10) obtained median MOD values of 115 mm for oocytes that survived but were not matured in vitro, 114 mm for IVM oocytes, and 113 mm for fertilized oocytes after ICSI, as opposed to the median value of mm obtained in our study. During the growth phase, the diameter of human oocytes increases from 30 to 110 mm over a period of at least 8 weeks (20). The diameter of IVM oocytes, excluding the zona pellucida, usually is 110 to 120 mm, while the thickness of the zona pellucida is 15 to 20 mm (11). However, as also concluded by Griffin et al. (8), it is possible that for mature oocytes the relations between oocyte diameter and degree of maturation are species specific and should not be generalized or extrapolated to other animal models. We conclude that the MOD of mature oocytes does not seem to be related to the occurrence of fertilization or to the developmental quality of human embryos on days 2 and 3 after ICSI. Acknowledgments: The authors thank Maria Albina Verceze Bortolieiro, Maria Auxiliadora Padua, Maria Aparecida Carneiro Vasconcelos, Marilda Hatsumi Yamada Dantas, Roberta Cristina Giorgenon, and Sandra Aparecida Cavichollo Vianna. REFERENCES 1. Edwards R. Maturation in vitro of human oocytes. Lancet 1965;6: Crozet N, Motlik J, Sz oll osi D. Nucleolar fine structure and RNA synthesis in porcine oocytes during early stages of antrum formation. Biol Cell 1981;41: Schultz RM, Wassarman PM. Biochemical studies of mammalian oogenesis: protein synthesis during oocyte growth and meiotic maturation in the mouse. J Cell Sci 1977;24: Otoi T, Fujii M, Tanaka M, Ooka A, Suzuki T. Canine oocyte diameter in relation to meiotic competence and sperm penetration. Theriogenology 2000;54: Anguita B, Jimenez-Macedo AR, Izquierdo D, Mogas T, Paramio MT. Effect of oocyte diameter on meiotic competence, embryo development, p34 (cdc2) expression and MPF activity in prepubertal goat oocytes. Theriogenology 2007;67: Smedt De, Crozet N, Gall L. Morphological and functional changes accompanying the acquisition of meiotic competence in ovarian goat oocyte. J Exp Zoo 1994;269: Martino A, Mogas T, Palomo M, Paramio M. Meiotic competence of prepubertal goat oocytes. Theriogenology 1994;41: Griffin J, Emery BR, Huang I, Peterson CM, Carrell DT. Comparative analysis of follicle morphology and oocyte diameter in four mammalian species (mouse, hamster, pig, and human). J Exp Clin Assist Reprod 2006;3: Durinzi KL, Saniga EM, Lanzerdorf SE. The relationship between size and maturation in vitro in the unstimulated human oocyte. Fertil Steril 1995;63: Cavilla JL, Kenedy CR, Byskov AG, Hartshorne GM. Human immature oocytes grow during culture for IVM. Hum Reprod 2008;23: Veeck LL. Abnormal morphology of the human oocyte and conceptus. In: An atlas of human gametes and conceptuses. Carnforth, Lancashire, United Kindom: Parthenon, 1999: Eppig JJ, Schroeder AC. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation and fertilization invitro. Biol Reprod 1989;41: Hirao Y, Miyano T, Kato S. Acquisition of maturational competence in in vitro grown mouse oocytes. J Exp Zool 1993;267: Daniel SAJ, Armstrong DT, Gore-Langton RE. Growth and development of rat oocytes in vitro. Gamete Res 1989;24: Hirao Y, Nagai T, Kubo M, Miyano T, Miyake M, Kato S. In vitro growth and maturation of pig oocytes. J Reprod Fertil 1994;100: Fair T, Hyttel P, Greve T. Bovine oocyte diameter in relation to maturational competence and transcriptional activity. Mol Reprod Dev 1995;42: Bao S, Obata Y, Carroll J, Domeki I, Kono T. Epigenetic modifications necessary for normal development are established during oocyte growth in mice. Biol Reprod 2000;62: Schramm RD, Tennier MT, Boatman DE, Bavister BD. Chromatin configurations and meiotic competence of oocytes are related to follicular diameter in non-stimulated rhesus monkeys. Biol Reprod 1993;48: Cavilla JL, Kennedy CR, Baltsen M, Klentzeris LD, Byskov AG, Hartshorne GM. The effects of meiosis activating sterol on in vitro maturation and fertilization of human oocytes from stimulated and unstimulated ovaries. Hum Reprod 2001;16: Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;2:81 7. Fertility and Sterility â 625

A comparison of the effects of estrus cow. nuclear maturation of bovine oocytes

A comparison of the effects of estrus cow. nuclear maturation of bovine oocytes A comparison of the effects of estrus cow serum and fetal calf serum on in vitro nuclear maturation of bovine oocytes J Spiropoulos, SE Long University of Bristol, School of Veterinary Science, Department

More information

Oocyte maturation. A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2

Oocyte maturation. A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2 A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2 Centre for Early Human Development, Institute of Reproduction and Development, Monash University, Monash Medical Centre,

More information

Possible factors affecting the development of oocytes in in-vitro maturation

Possible factors affecting the development of oocytes in in-vitro maturation Human Reproduction Vol. 15, (Suppl. 5) pp. 11-17, 2000 Possible factors affecting the development of oocytes in in-vitro maturation Anne Lis Mikkelsen 1 ' 2, Steven Smith 1 and Svend Lindenberg 1 ^he Fertility

More information

Effects of Preservation of Porcine Oocytes by Dibutyryl Cyclic AMP on in vitro Maturation, Fertilization and Development

Effects of Preservation of Porcine Oocytes by Dibutyryl Cyclic AMP on in vitro Maturation, Fertilization and Development JARQ 45 (3), 295 300 (2011) http://www.jircas.affrc.go.jp of Porcine Oocytes Using dbcamp Effects of of Porcine Oocytes by Dibutyryl Cyclic AMP on in vitro Maturation, Fertilization and Development Dai-ichiro

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring

More information

Meiotic competence of in vitro grown goat oocytes

Meiotic competence of in vitro grown goat oocytes Journal of Reproduction and Fertility (2000) 118, 367 373 Meiotic competence of in vitro grown goat oocytes N. Crozet, M. Dahirel and L. Gall Institut National de la Recherche Agronomique, Unité de Physiologie

More information

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF) DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment

More information

IN VITRO MATURATION OF HUMAN OOCYTES

IN VITRO MATURATION OF HUMAN OOCYTES REVIEW ARTICLE IN VITRO MATURATION OF HUMAN OOCYTES Yu-Hung Lin 1,2, Jiann-Loung Hwang 1,3 * 1 Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, 2 School of Medicine, Fu Jen

More information

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes Human Reproduction Vol.22, No.7 pp. 1991 1995, 2007 Advance Access publication on May 18, 2007 doi:10.1093/humrep/dem124 Optimal ICSI timing after the first polar body extrusion in in vitro matured human

More information

Clinical ICSI in the horse:

Clinical ICSI in the horse: Clinical ICSI in the horse: differences and similarities to human in an in vitro maturation-based system Katrin Hinrichs College of Veterinary Medicine & Biomedical Sciences Texas A&M University Standard

More information

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach

More information

Article Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS

Article Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS RBMOnline - Vol 13. No 3. 2006 340 348 Reproductive BioMedicine Online; www.rbmonline.com/article/2328 on web 12 June 2006 Article Effect of gonadotrophin priming on in-vitro maturation of oocytes collected

More information

Effect of Bovine Follicular Fluid Added to the Maturation Medium on Sperm Penetration in Pig Oocytes Matured In Vitro

Effect of Bovine Follicular Fluid Added to the Maturation Medium on Sperm Penetration in Pig Oocytes Matured In Vitro Article Effect of Bovine Follicular Fluid Added to the Maturation Medium on Sperm Penetration in Pig Oocytes Matured In Vitro Abstract Naoki ISOBE Research Associate Graduate School for International Development

More information

Study on Several Factors Involved in IVF-ET of Human Beings

Study on Several Factors Involved in IVF-ET of Human Beings Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,

More information

Fertilization of in vitro matured human oocytes by intracytoplasmic sperm injection (ICSI) using ejaculated and testicular spermatozoa

Fertilization of in vitro matured human oocytes by intracytoplasmic sperm injection (ICSI) using ejaculated and testicular spermatozoa DOI: 10.1111/j.1745-7262.2005.00016.x. Original Article. Fertilization of in vitro matured human oocytes by intracytoplasmic sperm injection (ICSI) using ejaculated and testicular spermatozoa Yun Qian

More information

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas FAILED OOCYTE MATURATION A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas INTRODUCTION In our laboratory,we perform (X) IVF and (Y) ICSI per year with a success

More information

Ion currents and molecules involved in oocyte maturation, fertilization and embryo development

Ion currents and molecules involved in oocyte maturation, fertilization and embryo development Ion currents and molecules involved in oocyte maturation, fertilization and embryo development Dr. Elisabetta Tosti Animal Physiology and Evolution laboratory Stazione Zoologica, Naples, Italy Main steps

More information

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ;   adm.cgmh.org.tw). OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung

More information

For these reasons we hypothesized that, because the ICSI procedure can be performed in a few minutes by experienced

For these reasons we hypothesized that, because the ICSI procedure can be performed in a few minutes by experienced Use of a medium buffered with N-hydroxyethylpiperazine-N-ethanesulfonate (HEPES) in intracytoplasmic sperm injection procedures is detrimental to the outcome of in vitro fertlization Francesco Morgia,

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing

More information

Outline. Male Reproductive System Testes and Sperm Hormonal Regulation

Outline. Male Reproductive System Testes and Sperm Hormonal Regulation Outline Male Reproductive System Testes and Sperm Hormonal Regulation Female Reproductive System Genital Tract Hormonal Levels Uterine Cycle Fertilization and Pregnancy Control of Reproduction Infertility

More information

Reproductive BioMedicine Online (2010) 20, 634 638 www.sciencedirect.com www.rbmonline.com ARTICLE In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing

More information

Proceedings of the Society for Theriogenology Annual Conference 2014

Proceedings of the Society for Theriogenology Annual Conference 2014 www.ivis.org Proceedings of the Society for Theriogenology Annual Conference 2014 Aug. 6-9, 2014 Portland, OR, USA Next SFT Meeting: Aug. 5-8, 2015 San Antonio, TX, USA Reprinted in the IVIS website with

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

Animal Science 434! Tonic and Preovulatory Surge of GnRH! Tonic and Preovulatory Surge of GnRH! Lecture 11: The Follicular Phase of the Estrous Cycle!

Animal Science 434! Tonic and Preovulatory Surge of GnRH! Tonic and Preovulatory Surge of GnRH! Lecture 11: The Follicular Phase of the Estrous Cycle! Tonic and Preovulatory Surge of GnRH! Animal Science 434! Lecture 11: The Follicular Phase of the Estrous Cycle!! (-)! Hypothalamus! GnRH! Estradiol! (-)! Tonic and Preovulatory Surge of GnRH! Anterior!

More information

Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection

Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection Julie D. Lamb, M.D., a A. Musa Zamah, M.D., Ph.D., a Shehua Shen, M.D., a Charles

More information

Principles of Ovarian Stimulation

Principles of Ovarian Stimulation Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle

More information

MSOME I+II: A NEW CUT-OFF VALUE FOR MALE INFERTILITY AND EMBRYO DEVELOPMENT PREDICTION ON INTRACYTOPLASMIC SPERM INJECTION CYCLES

MSOME I+II: A NEW CUT-OFF VALUE FOR MALE INFERTILITY AND EMBRYO DEVELOPMENT PREDICTION ON INTRACYTOPLASMIC SPERM INJECTION CYCLES MSOME I+II: A NEW CUT-OFF VALUE FOR MALE INFERTILITY AND EMBRYO DEVELOPMENT PREDICTION ON INTRACYTOPLASMIC SPERM INJECTION CYCLES Edson Borges Jr 1,2, ; Bianca Ferrarini Zanetti 1,2, Daniela Paes de Almeida

More information

Role of embryo morphology in Intracytoplasmic Sperm Injection cycles for prediction of pregnancy

Role of embryo morphology in Intracytoplasmic Sperm Injection cycles for prediction of pregnancy Iranian Journal of Reproductive Medicine Vol.5. No.1. pp:23-27, Winter 2007 Role of embryo morphology in Intracytoplasmic Sperm Injection cycles for prediction of pregnancy Mir Mehrdad Farsi, Ph.D., Ali

More information

Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check

Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check David E. Reichman, M.D., Katharine V. Jackson, B.A., and

More information

Immature oocyte retrieval combined with in-vitro oocyte maturation

Immature oocyte retrieval combined with in-vitro oocyte maturation Immature oocyte retrieval combined with in-vitro oocyte maturation J.B.Russell The Center for Human Reproduction, 4745 Ogletown Stanton Road, Suite 111, Newark, DE 19713, USA Immature oocyte retrieval

More information

Adenosine Triphosphate Content in Human Unfertilized Oocytes, Undivided Zygotes and Embryos Unsuitable for Transfer or Cryopreservation

Adenosine Triphosphate Content in Human Unfertilized Oocytes, Undivided Zygotes and Embryos Unsuitable for Transfer or Cryopreservation The Journal of International Medical Research 2012; 40: 734 739 Adenosine Triphosphate Content in Human Unfertilized Oocytes, Undivided Zygotes and Embryos Unsuitable for Transfer or Cryopreservation J

More information

Limited recovery of meiotic spindles in living human oocytes after cooling rewarming observed using polarized light microscopy

Limited recovery of meiotic spindles in living human oocytes after cooling rewarming observed using polarized light microscopy Human Reproduction Vol.16, No.11 pp. 2374 2378, 2001 Limited recovery of meiotic spindles in living human oocytes after cooling rewarming observed using polarized light microscopy Wei-Hua Wang 1,2,4, Li

More information

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde Human Reproduction vol.14 no.1 pp.65 69, 1999 Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure

More information

A study of the effect of an extremely low oxygen concentration on the development of human embryos in assisted reproductive technology

A study of the effect of an extremely low oxygen concentration on the development of human embryos in assisted reproductive technology Reprod Med Biol (2010) 9:163 168 DOI 10.1007/s12522-010-0052-7 ORIGINAL ARTICLE A study of the effect of an extremely low oxygen concentration on the development of human embryos in assisted reproductive

More information

Influence of co-culture with oviductal epithelial cells on in vitro maturation of canine oocytes

Influence of co-culture with oviductal epithelial cells on in vitro maturation of canine oocytes Reprod. Nutr. Dev. 42 (2002) 265 273 265 INRA, EDP Sciences, 2002 DOI: 10.1051/rnd:2002024 Original article Influence of co-culture with oviductal epithelial cells on in vitro maturation of canine oocytes

More information

In vitro maturation of human oocytes for assisted reproduction

In vitro maturation of human oocytes for assisted reproduction MODERN TRENDS Edward E. Wallach, M.D. Associate Editor In vitro maturation of human oocytes for assisted reproduction Marcus W. Jurema, M.D., and Daniela Nogueira, Ph.D. Department of Obstetrics and Gynecology,

More information

Information Booklet. Exploring the causes of infertility and treatment options.

Information Booklet. Exploring the causes of infertility and treatment options. Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole

More information

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions

More information

Biology of fertility control. Higher Human Biology

Biology of fertility control. Higher Human Biology Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting

More information

The Human Menstrual Cycle

The Human Menstrual Cycle The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)

More information

Chapter 28: REPRODUCTIVE SYSTEM: MALE

Chapter 28: REPRODUCTIVE SYSTEM: MALE Chapter 28: REPRODUCTIVE SYSTEM: MALE I. FUNCTIONAL ANATOMY (Fig. 28.1) A. Testes: glands which produce male gametes, as well as glands producing testosterone 2. Seminiferous tubules (Fig.28.3; 28.5) a.

More information

The intra-follicular molecular biology mandating advancement of egg retrieval in some women

The intra-follicular molecular biology mandating advancement of egg retrieval in some women The intra-follicular molecular biology mandating advancement of egg retrieval in some women David H. Barad, USA Director of Assisted Reproductive Technology, The Center for Human Reproduction New York

More information

In Vitro Growth of Mouse Ovarian Preantral Follicles and the Capacity of Their Oocytes to Develop to the Blastocyst Stage

In Vitro Growth of Mouse Ovarian Preantral Follicles and the Capacity of Their Oocytes to Develop to the Blastocyst Stage FULL PAPER Theriogenology In Vitro Growth of Mouse Ovarian Preantral Follicles and the Capacity of Their Oocytes to Develop to the Blastocyst Stage Christopher BISHONGA 1), Yoshiyuki TAKAHASHI 1)*, Seiji

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI

Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI Int J Clin Exp Med 2016;9(7):14677-14683 www.ijcem.com /ISSN:1940-5901/IJCEM0026636 Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI

More information

10.7 The Reproductive Hormones

10.7 The Reproductive Hormones 10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid

More information

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should

More information

Meiotic competence in vitro of pig oocytes isolated from early antral follicles

Meiotic competence in vitro of pig oocytes isolated from early antral follicles Meiotic competence in vitro of pig oocytes isolated from early antral follicles J. Motlik, Nicole Crozet and J. Fulka Czechoslovak Academy of Sciences, Institute of Animal Physiology and Genetics, Department

More information

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic

More information

Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome

Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome Molina B. Dayal, M.D., M.P.H., Paul R. Gindoff, M.D., Abbaa Sarhan, M.D., Anil Dubey, Ph.D., Douglas

More information

Influence of maturation culture period on the development of canine oocytes after in vitro maturation and fertilization

Influence of maturation culture period on the development of canine oocytes after in vitro maturation and fertilization Reprod. Nutr. Dev. 44 (2004) 631 637 INRA, EDP Sciences, 2005 DOI: 10.1051/rnd:2004065 631 Original article Influence of maturation culture period on the development of canine oocytes after in vitro maturation

More information

In Vitro Fertilization and Embryo Transfer

In Vitro Fertilization and Embryo Transfer Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Role of total antioxidant capacity in the differential growth of human embryos in vitro

Role of total antioxidant capacity in the differential growth of human embryos in vitro IN VITRO FERTILIZATION Role of total antioxidant capacity in the differential growth of human embryos in vitro Mohamed Bedaiwy, M.D., a,b,e Ashok Agarwal, Ph.D., a,b,c Tamer M. Said, M.D., a,c Jeffery

More information

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles? J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation

More information

Chapter 27 The Reproductive System. MDufilho

Chapter 27 The Reproductive System. MDufilho Chapter 27 The Reproductive System 1 Figure 27.19 Events of oogenesis. Before birth Meiotic events 2n Oogonium (stem cell) Mitosis Follicle development in ovary Follicle cells Oocyte 2n Primary oocyte

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential Cronicon OPEN ACCESS Ling Jia*, Bo Xu*, Yu-sheng Liu and Xian-hong Tong Center for Reproductive Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, China *These authors contributed

More information

AP Biology Ch ANIMAL REPRODUCTION. Using only what you already know (you cannot look up anything) complete the chart below.

AP Biology Ch ANIMAL REPRODUCTION. Using only what you already know (you cannot look up anything) complete the chart below. AP Biology Ch. 46 - ANIMAL REPRODUCTION Using only what you already know (you cannot look up anything) complete the chart below. I. Overview of Animal Reproduction A. Both asexual and sexual reproduction

More information

Use of in vitro maturation for fertility preservation

Use of in vitro maturation for fertility preservation Use of in vitro maturation for fertility preservation G. Arroyo Servei de Medicina de la Reproducció Departament d Obstetrícia, Ginecologia i Reproducció INSTITUT UNIVERSITARI DEXEUS MEDICAL STRATEGY TO

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/24779

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Outlook Strategies in human in-vitro maturation and their clinical outcome

Outlook Strategies in human in-vitro maturation and their clinical outcome RBMOnline - Vol 10. No 5. 2005 593 599 Reproductive BioMedicine Online; www.rbmonline.com/article/1677 on web 11 March 2005 Outlook Strategies in human in-vitro maturation and their clinical outcome Dr

More information

Female Reproductive System. Lesson 10

Female Reproductive System. Lesson 10 Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System

More information

Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle

Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle IN VITRO FERTILIZATION Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle Sunny H. Jun, M.D., a Thomas O Leary, B.S., b Katharine

More information

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra

More information

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D., FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol

More information

In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles

In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles FERTILITY AND STERILITY VOL. 74, NO. 6, DECEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. In vitro maturation,

More information

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile

More information

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko

More information

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin

More information

Phases of the Ovarian Cycle

Phases of the Ovarian Cycle OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000

More information

in vitro fertilization

in vitro fertilization FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal

More information

a The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen; b The Fertility Clinic, Odense University

a The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen; b The Fertility Clinic, Odense University Impact of follicular-fluid meiosis-activating sterol in an albumin-based formulation on the incidence of human pre-embryos with chromosome abnormalities Anne Loft, M.D., a Søren Ziebe, M.Sc., a Karin Erb,

More information

DISCLOSURE. Presentation outline. 1. Oocyte quality: impact, acquisition and approaches. 2. Oocyte polarity: a feature of oocyte maturation

DISCLOSURE. Presentation outline. 1. Oocyte quality: impact, acquisition and approaches. 2. Oocyte polarity: a feature of oocyte maturation Oocyte polarity: a sign of oocyte quality? Carlos E. Plancha 1,2 1 Unidade de Biologia da Reprodução, Inst. Histologia e Biologia do Desenvolvimento,. Faculdade de Medicina de Lisboa, Portugal 2 CEMEARE

More information

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

ORIGINAL ARTICLE. Introduction. Hyo Young Park 1, Min Young Lee 2, Hyo Young Jeong 2, Yong Sook Rho 2, Sang Jin Song 1, Bum-Chae Choi 2

ORIGINAL ARTICLE. Introduction. Hyo Young Park 1, Min Young Lee 2, Hyo Young Jeong 2, Yong Sook Rho 2, Sang Jin Song 1, Bum-Chae Choi 2 ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):62-66 Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropinreleasing hormone

More information

Evaluation of sequential changes on 1 st meiotic division of goat oocytes in vitro

Evaluation of sequential changes on 1 st meiotic division of goat oocytes in vitro Journal of Agricultural Technology 2015 Vol. 11(8): 2539-2546 Available online http://www.ijat-aatsea.com ISSN 1686-9141 Evaluation of sequential changes on 1 st meiotic division of goat oocytes in vitro

More information

Production of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro

Production of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro FERTILITY AND STERILITY VOL. 71, NO. 1, JANUARY 1999 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Production of steroids

More information

Maria A. Manzanares, M.D., Jose Lui Gomez-Palomares, M.D., Elisabetta Ricciarelli, M.D., and Eleuterio R. Hernandez, M.D., Ph.D.

Maria A. Manzanares, M.D., Jose Lui Gomez-Palomares, M.D., Elisabetta Ricciarelli, M.D., and Eleuterio R. Hernandez, M.D., Ph.D. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol

More information

Chapter 36 Active Reading Guide Reproduction and Development

Chapter 36 Active Reading Guide Reproduction and Development Name: AP Biology Mr. Croft Chapter 36 Active Reading Guide Reproduction and Development Section 1 1. Distinguish between sexual reproduction and asexual reproduction. 2. Which form of reproduction: a.

More information

Predictive value of embryo grading for embryos with known outcomes

Predictive value of embryo grading for embryos with known outcomes Predictive value of embryo grading for embryos with known outcomes Vanessa N. Weitzman, M.D., Jennifer Schnee-Riesz, M.D., Claudio Benadiva, M.D., John Nulsen, M.D., Linda Siano, M.S., and Donald Maier,

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...

More information

In vitro growth and maturation of pig oocytes

In vitro growth and maturation of pig oocytes In vitro growth and maturation of pig oocytes Y. Hirao, T. Nagai, M. Kubo, T. Miyano, M. Miyake and S. Kato 1T/ie Graduate School of Science and Technology, Kobe University, Nada-ku, Kobe 657, Japan; 2Department

More information

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division

More information

Day 4 embryo selection is equal to Day 5 using a new embryo scoring system validated in single embryo transfers

Day 4 embryo selection is equal to Day 5 using a new embryo scoring system validated in single embryo transfers Human Reproduction Vol.23, No.7 pp. 1505 1510, 2008 Advance Access publication on February 21, 2008 doi:10.1093/humrep/dem419 Day 4 embryo selection is equal to Day 5 using a new embryo scoring system

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27

More information